Clinical and economic outcomes of medication therapy management services: The Minnesota experience

Brian J. Isetts, Stephen W. Schondelmeyer, Margaret B. Artz, Lois A. Lenarz, Alan H. Heaton, Wallace B. Wadd, Lawrence M. Brown, Robert J. Cipolle

Research output: Contribution to journalArticle

207 Citations (Scopus)

Abstract

Objectives: To (1) provide medication therapy management (MTM) services to patients, (2) measure the clinical effects associated with the provision of MTM services, (3) measure the percent of patients achieving Healthcare Effectiveness Data and Information Set (HEDIS) goals for hypertension and hyperlipidemia in the MTM services intervention group in relationship to a comparison group who did not receive MTM services, and (4) compare patients' total health expenditures for the year before and after receiving MTM services. Design: Prospective study. Setting: Six ambulatory clinics in Minnesota from August 1, 2001, to July 31, 2002. Patients: 285 intervention group patients with at least 1 of 12 medical conditions using prestudy health claims; 126 comparison group patients with hypertension and 126 patients with hyperlipidemia were selected among 9 clinics without MTM services for HEDIS analysis. Intervention: MTM services provided by pharmacists to BlueCross BlueShield health plan beneficiaries in collaboration with primary care providers. Main outcome measures: Drug therapy problems resolved; percentage of patients' goals of therapy achieved and meeting HEDIS measures for hypertension and hypercholesterolemia. Total health expenditures per person were measured for a 1-year period before and after enrolling patients in MTM services. Results: 637 drug therapy problems were resolved among 285 intervention patients, and the percentage of patients' goals of therapy achieved increased from 76% to 90%. HEDIS measures improved in the intervention group compared with the comparison group for hypertension (71% versus 59%) and cholesterol management (52% versus 30%). Total health expenditures decreased from $11,965 to $8,197 per person (n = 186, P < 0.0001). The reduction in total annual health expenditures exceeded the cost of providing MTM services by more than 12 to 1. Conclusion: Patients receiving face-to-face MTM services provided by pharmacists in collaboration with prescribers experienced improved clinical outcomes and lower total health expenditures. Clinical outcomes of MTM services have chronic care improvement and value-based purchasing implications, and economic outcomes support inclusion of MTM services in health plan design.

Original languageEnglish (US)
Pages (from-to)203-214
Number of pages12
JournalJournal of the American Pharmacists Association
Volume48
Issue number2
DOIs
StatePublished - Jan 1 2008

Fingerprint

Medication Therapy Management
Economics
Health
Health Expenditures
Hypertension
Delivery of Health Care
Drug therapy
Hyperlipidemias
Pharmacists
Value-Based Purchasing
Drug Therapy
Hypercholesterolemia
Purchasing
Health Services

Keywords

  • Chronic disease
  • Collaborative practice
  • Economics
  • Medication therapy management services
  • Pharmaceutical care

Cite this

Clinical and economic outcomes of medication therapy management services : The Minnesota experience. / Isetts, Brian J.; Schondelmeyer, Stephen W.; Artz, Margaret B.; Lenarz, Lois A.; Heaton, Alan H.; Wadd, Wallace B.; Brown, Lawrence M.; Cipolle, Robert J.

In: Journal of the American Pharmacists Association, Vol. 48, No. 2, 01.01.2008, p. 203-214.

Research output: Contribution to journalArticle

Isetts, Brian J. ; Schondelmeyer, Stephen W. ; Artz, Margaret B. ; Lenarz, Lois A. ; Heaton, Alan H. ; Wadd, Wallace B. ; Brown, Lawrence M. ; Cipolle, Robert J. / Clinical and economic outcomes of medication therapy management services : The Minnesota experience. In: Journal of the American Pharmacists Association. 2008 ; Vol. 48, No. 2. pp. 203-214.
@article{19a345cf9bf447fcbd67fcefa7f673e9,
title = "Clinical and economic outcomes of medication therapy management services: The Minnesota experience",
abstract = "Objectives: To (1) provide medication therapy management (MTM) services to patients, (2) measure the clinical effects associated with the provision of MTM services, (3) measure the percent of patients achieving Healthcare Effectiveness Data and Information Set (HEDIS) goals for hypertension and hyperlipidemia in the MTM services intervention group in relationship to a comparison group who did not receive MTM services, and (4) compare patients' total health expenditures for the year before and after receiving MTM services. Design: Prospective study. Setting: Six ambulatory clinics in Minnesota from August 1, 2001, to July 31, 2002. Patients: 285 intervention group patients with at least 1 of 12 medical conditions using prestudy health claims; 126 comparison group patients with hypertension and 126 patients with hyperlipidemia were selected among 9 clinics without MTM services for HEDIS analysis. Intervention: MTM services provided by pharmacists to BlueCross BlueShield health plan beneficiaries in collaboration with primary care providers. Main outcome measures: Drug therapy problems resolved; percentage of patients' goals of therapy achieved and meeting HEDIS measures for hypertension and hypercholesterolemia. Total health expenditures per person were measured for a 1-year period before and after enrolling patients in MTM services. Results: 637 drug therapy problems were resolved among 285 intervention patients, and the percentage of patients' goals of therapy achieved increased from 76{\%} to 90{\%}. HEDIS measures improved in the intervention group compared with the comparison group for hypertension (71{\%} versus 59{\%}) and cholesterol management (52{\%} versus 30{\%}). Total health expenditures decreased from $11,965 to $8,197 per person (n = 186, P < 0.0001). The reduction in total annual health expenditures exceeded the cost of providing MTM services by more than 12 to 1. Conclusion: Patients receiving face-to-face MTM services provided by pharmacists in collaboration with prescribers experienced improved clinical outcomes and lower total health expenditures. Clinical outcomes of MTM services have chronic care improvement and value-based purchasing implications, and economic outcomes support inclusion of MTM services in health plan design.",
keywords = "Chronic disease, Collaborative practice, Economics, Medication therapy management services, Pharmaceutical care",
author = "Isetts, {Brian J.} and Schondelmeyer, {Stephen W.} and Artz, {Margaret B.} and Lenarz, {Lois A.} and Heaton, {Alan H.} and Wadd, {Wallace B.} and Brown, {Lawrence M.} and Cipolle, {Robert J.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1331/JAPhA.2008.07108",
language = "English (US)",
volume = "48",
pages = "203--214",
journal = "Journal of the American Pharmacists Association : JAPhA",
issn = "1544-3191",
publisher = "American Pharmacists Association",
number = "2",

}

TY - JOUR

T1 - Clinical and economic outcomes of medication therapy management services

T2 - The Minnesota experience

AU - Isetts, Brian J.

AU - Schondelmeyer, Stephen W.

AU - Artz, Margaret B.

AU - Lenarz, Lois A.

AU - Heaton, Alan H.

AU - Wadd, Wallace B.

AU - Brown, Lawrence M.

AU - Cipolle, Robert J.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Objectives: To (1) provide medication therapy management (MTM) services to patients, (2) measure the clinical effects associated with the provision of MTM services, (3) measure the percent of patients achieving Healthcare Effectiveness Data and Information Set (HEDIS) goals for hypertension and hyperlipidemia in the MTM services intervention group in relationship to a comparison group who did not receive MTM services, and (4) compare patients' total health expenditures for the year before and after receiving MTM services. Design: Prospective study. Setting: Six ambulatory clinics in Minnesota from August 1, 2001, to July 31, 2002. Patients: 285 intervention group patients with at least 1 of 12 medical conditions using prestudy health claims; 126 comparison group patients with hypertension and 126 patients with hyperlipidemia were selected among 9 clinics without MTM services for HEDIS analysis. Intervention: MTM services provided by pharmacists to BlueCross BlueShield health plan beneficiaries in collaboration with primary care providers. Main outcome measures: Drug therapy problems resolved; percentage of patients' goals of therapy achieved and meeting HEDIS measures for hypertension and hypercholesterolemia. Total health expenditures per person were measured for a 1-year period before and after enrolling patients in MTM services. Results: 637 drug therapy problems were resolved among 285 intervention patients, and the percentage of patients' goals of therapy achieved increased from 76% to 90%. HEDIS measures improved in the intervention group compared with the comparison group for hypertension (71% versus 59%) and cholesterol management (52% versus 30%). Total health expenditures decreased from $11,965 to $8,197 per person (n = 186, P < 0.0001). The reduction in total annual health expenditures exceeded the cost of providing MTM services by more than 12 to 1. Conclusion: Patients receiving face-to-face MTM services provided by pharmacists in collaboration with prescribers experienced improved clinical outcomes and lower total health expenditures. Clinical outcomes of MTM services have chronic care improvement and value-based purchasing implications, and economic outcomes support inclusion of MTM services in health plan design.

AB - Objectives: To (1) provide medication therapy management (MTM) services to patients, (2) measure the clinical effects associated with the provision of MTM services, (3) measure the percent of patients achieving Healthcare Effectiveness Data and Information Set (HEDIS) goals for hypertension and hyperlipidemia in the MTM services intervention group in relationship to a comparison group who did not receive MTM services, and (4) compare patients' total health expenditures for the year before and after receiving MTM services. Design: Prospective study. Setting: Six ambulatory clinics in Minnesota from August 1, 2001, to July 31, 2002. Patients: 285 intervention group patients with at least 1 of 12 medical conditions using prestudy health claims; 126 comparison group patients with hypertension and 126 patients with hyperlipidemia were selected among 9 clinics without MTM services for HEDIS analysis. Intervention: MTM services provided by pharmacists to BlueCross BlueShield health plan beneficiaries in collaboration with primary care providers. Main outcome measures: Drug therapy problems resolved; percentage of patients' goals of therapy achieved and meeting HEDIS measures for hypertension and hypercholesterolemia. Total health expenditures per person were measured for a 1-year period before and after enrolling patients in MTM services. Results: 637 drug therapy problems were resolved among 285 intervention patients, and the percentage of patients' goals of therapy achieved increased from 76% to 90%. HEDIS measures improved in the intervention group compared with the comparison group for hypertension (71% versus 59%) and cholesterol management (52% versus 30%). Total health expenditures decreased from $11,965 to $8,197 per person (n = 186, P < 0.0001). The reduction in total annual health expenditures exceeded the cost of providing MTM services by more than 12 to 1. Conclusion: Patients receiving face-to-face MTM services provided by pharmacists in collaboration with prescribers experienced improved clinical outcomes and lower total health expenditures. Clinical outcomes of MTM services have chronic care improvement and value-based purchasing implications, and economic outcomes support inclusion of MTM services in health plan design.

KW - Chronic disease

KW - Collaborative practice

KW - Economics

KW - Medication therapy management services

KW - Pharmaceutical care

UR - http://www.scopus.com/inward/record.url?scp=42149166879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149166879&partnerID=8YFLogxK

U2 - 10.1331/JAPhA.2008.07108

DO - 10.1331/JAPhA.2008.07108

M3 - Article

C2 - 18359733

AN - SCOPUS:42149166879

VL - 48

SP - 203

EP - 214

JO - Journal of the American Pharmacists Association : JAPhA

JF - Journal of the American Pharmacists Association : JAPhA

SN - 1544-3191

IS - 2

ER -